318 related articles for article (PubMed ID: 22804241)
1. Heat shock proteins (HSPs) based anti-cancer vaccines.
Ciocca DR; Cayado-Gutierrez N; Maccioni M; Cuello-Carrion FD
Curr Mol Med; 2012 Nov; 12(9):1183-97. PubMed ID: 22804241
[TBL] [Abstract][Full Text] [Related]
2. Heat-shock proteins in cancer vaccines: agents of antigen cross-presentation.
Murshid A; Gong J; Calderwood SK
Expert Rev Vaccines; 2008 Sep; 7(7):1019-30. PubMed ID: 18767951
[TBL] [Abstract][Full Text] [Related]
3. Heat shock proteins and cancer immunotherapy.
Wang XY; Kaneko Y; Repasky E; Subjeck JR
Immunol Invest; 2000 May; 29(2):131-7. PubMed ID: 10854181
[TBL] [Abstract][Full Text] [Related]
4. Heat-shock protein-peptide complex-96 for the treatment of cancer.
Amato RJ
Expert Opin Biol Ther; 2007 Aug; 7(8):1267-73. PubMed ID: 17696824
[TBL] [Abstract][Full Text] [Related]
5. Heat-shock protein-based anticancer immunotherapy: an idea whose time has come.
Ménoret A; Chandawarkar R
Semin Oncol; 1998 Dec; 25(6):654-60. PubMed ID: 9865680
[TBL] [Abstract][Full Text] [Related]
6. Bacterial heat shock proteins promote CD91-dependent class I MHC cross-presentation of chaperoned peptide to CD8+ T cells by cytosolic mechanisms in dendritic cells versus vacuolar mechanisms in macrophages.
Tobian AA; Canaday DH; Boom WH; Harding CV
J Immunol; 2004 May; 172(9):5277-86. PubMed ID: 15100266
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy of cancer using heat shock proteins.
Manjili MH; Wang XY; Park J; Facciponte JG; Repasky EA; Subjeck JR
Front Biosci; 2002 Jan; 7():d43-52. PubMed ID: 11779704
[TBL] [Abstract][Full Text] [Related]
8. Heat shock protein--peptide complexes as immunotherapy for human cancer.
Przepiorka D; Srivastava PK
Mol Med Today; 1998 Nov; 4(11):478-84. PubMed ID: 9857367
[TBL] [Abstract][Full Text] [Related]
9. Heat shock protein-based cancer vaccines.
Oki Y; Younes A
Expert Rev Vaccines; 2004 Aug; 3(4):403-11. PubMed ID: 15270645
[TBL] [Abstract][Full Text] [Related]
10. Cancer vaccine--Antigenics.
BioDrugs; 2002; 16(1):72-4. PubMed ID: 11909004
[TBL] [Abstract][Full Text] [Related]
11. Heat shock proteins and the antitumor T cell response.
Harada M; Kimura G; Nomoto K
Biotherapy; 1998; 10(3):229-35. PubMed ID: 9559978
[TBL] [Abstract][Full Text] [Related]
12. Antigen-specific vaccines for cancer treatment.
Tagliamonte M; Petrizzo A; Tornesello ML; Buonaguro FM; Buonaguro L
Hum Vaccin Immunother; 2014; 10(11):3332-46. PubMed ID: 25483639
[TBL] [Abstract][Full Text] [Related]
13. Heat shock protein vaccines: from bench to bedside.
Binder RJ
Int Rev Immunol; 2006; 25(5-6):353-75. PubMed ID: 17169780
[TBL] [Abstract][Full Text] [Related]
14. Bacterial heat shock proteins enhance class II MHC antigen processing and presentation of chaperoned peptides to CD4+ T cells.
Tobian AA; Canaday DH; Harding CV
J Immunol; 2004 Oct; 173(8):5130-7. PubMed ID: 15470057
[TBL] [Abstract][Full Text] [Related]
15. Cell stress proteins: novel immunotherapeutics.
Calderwood SK; Gong J; Theriault JR; Mambula SS; Gray PJ
Novartis Found Symp; 2008; 291():115-31; discussion 131-40. PubMed ID: 18575270
[TBL] [Abstract][Full Text] [Related]
16. Melanoma-reactive class I-restricted cytotoxic T cell clones are stimulated by dendritic cells loaded with synthetic peptides, but fail to respond to dendritic cells pulsed with melanoma-derived heat shock proteins in vitro.
Fleischer K; Schmidt B; Kastenmüller W; Busch DH; Drexler I; Sutter G; Heike M; Peschel C; Bernhard H
J Immunol; 2004 Jan; 172(1):162-9. PubMed ID: 14688322
[TBL] [Abstract][Full Text] [Related]
17. Immunization of cancer patients with autologous cancer-derived heat shock protein gp96 preparations: a pilot study.
Janetzki S; Palla D; Rosenhauer V; Lochs H; Lewis JJ; Srivastava PK
Int J Cancer; 2000 Oct; 88(2):232-8. PubMed ID: 11004674
[TBL] [Abstract][Full Text] [Related]
18. Heat-shock proteins-based immunotherapy for advanced melanoma in the era of target therapies and immunomodulating agents.
Tosti G; Cocorocchio E; Pennacchioli E; Ferrucci PF; Testori A; Martinoli C
Expert Opin Biol Ther; 2014 Jul; 14(7):955-67. PubMed ID: 24670226
[TBL] [Abstract][Full Text] [Related]
19. Hsp receptors: the cases of identity and mistaken identity.
Binder RJ
Curr Opin Mol Ther; 2009 Feb; 11(1):62-71. PubMed ID: 19169961
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in heat shock protein-based cancer vaccines.
Wang HH; Mao CY; Teng LS; Cao J
Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):22-7. PubMed ID: 16481277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
